NEWS
Jan 4, 2023
Actimed Therapeutics successfully closes second tranche of £10m seed financing to progress pipeline for treatment of cancer cachexia and other muscle wasting disorders
Jan 2, 2023
Actimed Therapeutics to Present Company Progress at Biotech Showcase 2023 in San Francisco
Management Team